Literature DB >> 31560860

Hypoxic niches are endowed with a protumorigenic mechanism that supersedes the protective function of PTEN.

Carlos H V Nascimento-Filho1,2, Liana P Webber1,3, Gabriell B Borgato1,4, Eny M Goloni-Bertollo2, Cristiane H Squarize1,5, Rogerio M Castilho1,5.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide and is characterized by a fast-paced growth. Like other solid tumors, the HNSCC growth rate results in the development of hypoxic regions identified by the expression of hypoxia-inducible factor 1α (HIF-1α). Interestingly, clinical data have shown that pharmacological induction of intratumoral hypoxia caused an unexpected rise in tumor metastasis and the accumulation of cancer stem cells (CSCs). However, little is known on the molecular circuitries involved in the presence of intratumoral hypoxia and the augmented population of CSCs. Here we explore the impact of hypoxia on the behavior of HNSCC and define that the controlling function of phosphatase and tensin homolog (PTEN) over HIF-1α expression and CSC accumulation are de-regulated during hypoxic events. Our findings indicate that hypoxic niches are poised to accumulate CSCs in a molecular process driven by the loss of PTEN activity. Furthermore, our data suggest that targeted therapies aiming at the PTEN/PI3K signaling may constitute an effective strategy to counteract the development of intratumoral hypoxia and the accumulation of CSCs.-Nascimento-Filho, C. H. V., Webber, L. P., Borgato, G. B., Goloni-Bertollo, E. M., Squarize, C. H., Castilho, R. M. Hypoxic niches are endowed with a protumorigenic mechanism that supersedes the protective function of PTEN.

Entities:  

Keywords:  EMT; ROS; cancer stem cell; epithelial-mesenchymal transition; mTOR

Mesh:

Substances:

Year:  2019        PMID: 31560860      PMCID: PMC6894060          DOI: 10.1096/fj.201900722R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.834


  55 in total

Review 1.  What's taking so long? S-phase entry from quiescence versus proliferation.

Authors:  Hilary A Coller
Journal:  Nat Rev Mol Cell Biol       Date:  2007-08       Impact factor: 94.444

2.  Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG.

Authors:  Annett Linge; Steffen Löck; Volker Gudziol; Alexander Nowak; Fabian Lohaus; Cläre von Neubeck; Martin Jütz; Amir Abdollahi; Jürgen Debus; Inge Tinhofer; Volker Budach; Ali Sak; Martin Stuschke; Panagiotis Balermpas; Claus Rödel; Melanie Avlar; Anca-Ligia Grosu; Christine Bayer; Claus Belka; Steffi Pigorsch; Stephanie E Combs; Stefan Welz; Daniel Zips; Frank Buchholz; Daniela E Aust; Gustavo B Baretton; Howard D Thames; Anna Dubrovska; Jan Alsner; Jens Overgaard; Michael Baumann; Mechthild Krause
Journal:  Clin Cancer Res       Date:  2016-01-11       Impact factor: 12.531

3.  The determinants of head and neck cancer: Unmasking the PI3K pathway mutations.

Authors:  Fernanda S Giudice; Cristiane H Squarize
Journal:  J Carcinog Mutagen       Date:  2013-08-02

4.  HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.

Authors:  Yoshifumi Baba; Katsuhiko Nosho; Kaori Shima; Natsumi Irahara; Andrew T Chan; Jeffrey A Meyerhardt; Daniel C Chung; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

5.  Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.

Authors:  Christine C Hudson; Mei Liu; Gary G Chiang; Diane M Otterness; Dawn C Loomis; Fiona Kaper; Amato J Giaccia; Robert T Abraham
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 6.  Modes of resistance to anti-angiogenic therapy.

Authors:  Gabriele Bergers; Douglas Hanahan
Journal:  Nat Rev Cancer       Date:  2008-08       Impact factor: 60.716

7.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

8.  The effects of short-term hypoxia on human mesenchymal stem cell proliferation, viability and p16(INK4A) mRNA expression: Investigation using a simple hypoxic culture system with a deoxidizing agent.

Authors:  Akira Ito; Tomoki Aoyama; Makoto Yoshizawa; Momoko Nagai; Junichi Tajino; Shoki Yamaguchi; Hirotaka Iijima; Xiangkai Zhang; Hiroshi Kuroki
Journal:  J Stem Cells Regen Med       Date:  2015-05-30

9.  Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers.

Authors:  Shingo Nakahata; Tomonaga Ichikawa; Phudit Maneesaay; Yusuke Saito; Kentaro Nagai; Tomohiro Tamura; Nawin Manachai; Norio Yamakawa; Makoto Hamasaki; Issay Kitabayashi; Yasuhito Arai; Yae Kanai; Tomohiko Taki; Takaya Abe; Hiroshi Kiyonari; Kazuya Shimoda; Koichi Ohshima; Akira Horii; Hiroshi Shima; Masafumi Taniwaki; Ryoji Yamaguchi; Kazuhiro Morishita
Journal:  Nat Commun       Date:  2014-02-26       Impact factor: 14.919

10.  Loss of NDRG2 enhanced activation of the NF-κB pathway by PTEN and NIK phosphorylation for ATL and other cancer development.

Authors:  Tomonaga Ichikawa; Shingo Nakahata; Masahiro Fujii; Hidekatsu Iha; Kazuhiro Morishita
Journal:  Sci Rep       Date:  2015-08-13       Impact factor: 4.379

View more
  4 in total

1.  From Tissue Physoxia to Cancer Hypoxia, Cost-Effective Methods to Study Tissue-Specific O2 Levels in Cellular Biology.

Authors:  Carlos H V Nascimento-Filho; Alexandra T Glinos; Yeejin Jang; Eny M Goloni-Bertollo; Rogerio M Castilho; Cristiane H Squarize
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

Review 2.  CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.

Authors:  María Auxiliadora Olivares-Urbano; Carmen Griñán-Lisón; Juan Antonio Marchal; María Isabel Núñez
Journal:  Cells       Date:  2020-07-09       Impact factor: 6.600

Review 3.  Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems.

Authors:  Aadya Nayak; Neerada Meenakshi Warrier; Praveen Kumar
Journal:  Stem Cell Rev Rep       Date:  2022-07-25       Impact factor: 6.692

Review 4.  Targeting Hypoxia-Driven Metabolic Reprogramming to Constrain Tumor Progression and Metastasis.

Authors:  Marisol Miranda-Galvis; Yong Teng
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.